期刊文献+

骨髓间充质干细胞移植治疗实验性大鼠肺动脉高压损伤的作用 被引量:4

Effect of mesenchymal stem cells implantation on experimental impairment caused by pulmonary arterial hypertension in rats
原文传递
导出
摘要 目的探讨骨髓间充质干细胞(M SC s)移植治疗肺动脉高压(PAH)致右心室损伤的作用效果及其机制,观察M SC s移植后存活及转化情况。方法取SD大鼠骨髓,经贴壁筛选法体外培养并纯化M SC s,CM-D iI荧光染料标记后备用。将实验动物随机分为M SC s移植治疗组(M SC s组)、肺动脉高压模型组(PAH组)和生理盐水阴性对照组(对照组),每组10只。M SC s组和PAH组大鼠皮下注射野百合碱(MCT)建立肺动脉高压模型,对照组皮下注射等量0.9%生理盐水代替MCT;1周后M SC s组大鼠经舌下静脉注射M SC s细胞悬液1mL,对照组及PAH组注射等量低糖DM EM液。移植3周后荧光显微镜下观察M SC s体内存活及转化情况,并对右心室(RV)肥厚和右心室收缩压(RVSP)升高情况进行评价。结果 M SC s在大鼠体内能存活至少3周,荧光显微镜可见M SC s转化为血管平滑肌细胞,与PAH组相比,M SC s组RVSP及RV质量与体质量比值明显降低。结论静脉移植M SC s可明显减轻甚至逆转MCT诱导的肺动脉高压的进程,改善心功能及血流动力学指标,其机制可能是通过旁分泌作用实现的。 Objective To investigate the therapeutic mechanism of bone marrow mesenchymal stem cells (MSCs) transplantation on the model of pulmonary arterial hypertension (PAH) and observe the survived and transformed MSCs in PAH after 3weeks. Methods MSCs were isolated, cultured from bone marrow of SD rats, and stained with CM-DiI fluoresence dye in vitro. The rats were randomly divided into three groups (n = 10) : the MSCs group, the non-treat- ment group (PAH group) and the control group. The PAH model was induced by subcutaneous injection of MCT in MSCs and PAH groups, the rats of the control group were injected with normal saline instead of MCT. One week after MCT administration, MSCs were injected through the ranine vein into rats in the MSCs group. At the same time, rats in PAH and control groups were injected with low-glucose DMEM. Three weeks after the injection, the bone marrow- derived mesenchymal stem cell survival and transformation were observed by immunofluorescence microscopy. Right ventricular (RV) hypertrophy and elevation of RV systolic pressure (RVSP) were evaluated. Result Immunofluores- cence and histochemical results confirmed that transplanted MSCs were still alive after 3 weeks, and some of them ap- peared to differentiate into pulmonary vascular endothelial cells. Compared with the PAH group, RV hypertrophy andRVSP were significantly decreased. Conclusion Intravenous implantation of MSCs can significantly reduce or even re- verse progression of MCT-induced pulmonary arterial hypertension to improve cardiac function and hemodynamics. The mechanism may be attributed to paracrine effects.
出处 《山东大学学报(医学版)》 CAS 北大核心 2011年第8期31-34,40,共5页 Journal of Shandong University:Health Sciences
关键词 骨髓间充质干细胞 移植 肺动脉高压 右心室损伤 Mesenchymal stem cells Transplantation Pulmonary arterial hypertension Right ventricular impairments
  • 相关文献

参考文献10

  • 1Morrell N W, Adnot S, Archer S L, et al. Cellular and molecular basis of pulmonary arterial hypertension [ J ]. J Am Coll Cardiol, 2009, 54( I Suppl) :S20-S31. 被引量:1
  • 2Patel K M, Crisostomo P, Lahm T, et al. Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism[ J ]. Journal of Surgical Research, 2007, 143 (2) :281-285. 被引量:1
  • 3Harada-Shiba M, Takamisawa I, Miyata K, et al. Intratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates rnonocrotaline-induced pulmonary hypertension in rats[J]. Mol Ther, 2009, 17 (7) : 1180- 1186. 被引量:1
  • 4Kanki-Horimoto S, Horimoto H, Mieno S, et al. Implantation of mesenchymal stem ceils overexpressing endothelial nitric oxide synthase improves right ventricular impair ments caused by pulmonary hypertension [ J ]. Circulation, 2006, 114( 1 Suppl) :181-185. 被引量:1
  • 5Takemiya K, Kai H, Yasukawa H, et al. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats [J]. Basic Res Cardiol, 2010, 105 ( 3 ) :409-417. 被引量:1
  • 6Cohen E D, Ihida-Stansbury K, Lu M M, et al. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway [J]. J Clin Invest, 2009, 119(9) :2538-2549. 被引量:1
  • 7Pittenger M F, Martin B J. Mesenchyma stern cells and their potential as cardiac therapeutics[J].Circulation Research, 2004, 95:9-20. 被引量:1
  • 8Wollert K C, Drexler H. Mesenchymal stem cells for myocardial infarction: Promises and pitfalls[J].Circulation, 2005, 112 : 151-153. 被引量:1
  • 9Chang L T, Sun C K, Sheu J J, et al. Cilostazol therapy attenuates monomonocrotaline-induced pulmonary arterial hypertension in rat model [J]. Circ, 2008, 72(5) :825-831. 被引量:1
  • 10Badillo A T, Redden R A, Zhang L. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhance wound closure [ J ]. Cell Tissue Res, 2007, 329(2) :301-311. 被引量:1

同被引文献73

  • 1赵永红,苏肇伉,张海波,陈会文,蒋祖明,邹文艳.脱氢野百合碱诱导犬肺动脉高压模型的建立[J].中华胸心血管外科杂志,2005,21(6):346-348. 被引量:11
  • 2高峰,蔡振杰,李利,郑奇军,刘维永.血管内皮生长因子基因转染骨髓间充质干细胞移植促进缺血心肌血管生成的研究[J].中国实用内科杂志:临床前沿版,2006,26(10):1600-1602. 被引量:6
  • 3魏来,赵强,陈安清,陆军,姚瑞明,贾剑国,王克强,邹云增.右侧全肺切除致大鼠动力型肺动脉高压模型的建立[J].中国临床医学,2007,14(4):482-484. 被引量:5
  • 4Takemiya K, Kai H,Yasukawa H,et al. Mesenchymalstem cell-based prostacyclin synthase gene therapy forpulmonary hypertention rats [ J] . Basic Res Cardiol,2010, 105 (3) : 409417. 被引量:1
  • 5Jaumdally RJ, Goon PK,Varma C, et al. Effects ofatorvastatin on circulating CD34 + /CD133 + /CD45-pro-genitor cells and indices of angiogenesis ( vascular endo-thelial growth factor and the angiopoietins 1 and 2 ) inatherosclerotic vascular disease and diabetas mellitus[J] .J Intern Med, 2010,267 (4) : 385-393. 被引量:1
  • 6KANKI-HORIMOTO S, HORIMOTO H, MIENO S, et al.Implantation of mesenchymal stem cells overexpressing endo-thelial nitric oxide synthase improves right ventricular impair-ments caused by pulmonary hypertension [J], Circulation,2006,114: I-181-1- 185. 被引量:1
  • 7YILDIZ P. Molecular mechanisms of pulmonary hypertension[J]. Clin Chim Acta, 2009, 403(1-2): 9-16. 被引量:1
  • 8CAN M M, TANBOGA I H,DEMIRCAN H C,et al. En-hanced hemostatic indices in patients with pulmonary arterialhypertension: an observational study [J]. Thromb Res,2010, 126(4) : 280*282. 被引量:1
  • 9MORRELL N W,ADNOT S, ARCHER S L, et al. CellularAm Coll Cardiol? 2009,54(1 Suppl) : S20-S31. 被引量:1
  • 10YOSHIDA H,KITAICHI T,URATA M,et al. Syngeneicbone marrow mononuclear cells improve pulmonary arterialhypertension through vascular endothelial growth factor up-regulation [Jj. Ann Thorac Surg, 2009,88(2) : 418-424. 被引量:1

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部